LENZ Therapeutics (LENZ) Tax Rate (2024 - 2026)
LENZ Therapeutics (LENZ) posted quarterly Tax Rate of 0.01% for Q4 2025, little changed year-over-year from 0.01% in Q4 2024, and up 99.84% quarter-over-quarter from 3.47% in Q2 2025.
LENZ Therapeutics (LENZ) Tax Rate (2024 - 2026) Analysis & Trends
LENZ Therapeutics (LENZ) has reported Tax Rate for 2 consecutive years, with 0.01% the latest figure, recorded in Q4 2025.
- In Q4 2025, Tax Rate changed 0.0% year-over-year to 0.01%; the TTM figure through Dec 2025 stood at 0.61% (changed N/A YoY), while the FY2025 annual figure was 0.62%, down 61.0% from the prior year.
- Tax Rate climbed to 0.01% in Q4 2025 per LENZ's latest filing, from 3.47% in the prior quarter.
- Across five years, Tax Rate topped out at 0.01% in Q4 2025 and bottomed at 3.47% in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 20.98% |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 15.11% |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 10.91% |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -1.96% |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 24.15% |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 7.49% |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -16.71% |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 34.12% |
| 10 | LENZ Therapeutics | 146.20 Mn | 146.20 Mn | 5.21 Mn | -0.01% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.01% |
| Jun 30, 2026 | -0.01% |
| Jun 30, 2026 | -0.01% |
| Dec 31, 2025 | -0.01% |
| Dec 31, 2025 | -0.01% |
| Dec 31, 2025 | -0.01% |
| Jun 30, 2025 | -3.47% |
| Jun 30, 2025 | -3.47% |
| Jun 30, 2025 | -3.47% |
| Dec 31, 2024 | -0.01% |
| Dec 31, 2024 | -0.01% |
| Dec 31, 2024 | -0.01% |